糖尿病视网膜病变全球患病率及2045年负担预测:系统综述与荟萃分析
该研究通过系统综述和荟萃分析纳入59项人群研究,估计糖尿病患者中糖尿病视网膜病变(DR)全球患病率为22.27%,视力威胁性DR(VTDR)为6.17%,临床显著性黄斑水肿(CSME)为4.07%。
要点
- 糖尿病患者中DR全球患病率为22.27%,VTDR为6.17%,CSME为4.07%。
- 非洲DR患病率最高(35.90%),南美洲和中美洲最低(13.37%)。
核心结论
- 全球DR负担至2045年预计仍将居高不下,中东和北非及西太平洋地区受累尤为严重。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Medline、Web of Science和Scopus截至2020年3月发表的人群研究,最终纳入59项研究。
- 采用随机效应荟萃分析及logit转换估计全球和区域DR、VTDR、CSME患病率,并基于IDF Atlas 2019人口数据预测负担。
主要发现
- 糖尿病患者中DR全球患病率为22.27%(95%CI 19.73%-25.03%),VTDR为6.17%(95%CI 5.43%-6.98%),CSME为4.07%(95%CI 3.42%-4.82%)。
- DR患病率非洲最高(35.90%),北美和加勒比地区为33.30%,南美洲和中美洲最低(13.37%)。
- 在调整居住类型、应答率、研究年份和DR诊断方法的荟萃回归模型中,西班牙裔(OR 2.92,95%CI 1.22-6.98)和中东裔(OR 2.44,95%CI 1.51-3.94)糖尿病患者相比亚洲裔更易患DR。
临床怎么用
- 全球DR负担预测可指导DR筛查、治疗和公共卫生保健策略的制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: To provide updated estimates on the global prevalence and number of people with diabetic retinopathy (DR) through 2045. CLINICAL RELEVANCE: The International Diabetes Federation (IDF) estimated the global population with diabetes mellitus (DM) to be 463 million in 2019 and 700 million in 2045. Diabetic retinopathy remains a common complication of DM and a leading cause of preventable blindness in the adult working population. METHODS: We conducted a systematic review using PubMed, Medline, Web of Science, and Scopus for population-based studies published up to March 2020. Random effect meta-analysis with logit transformation was performed to estimate global and regional prevalence of DR, vision-threatening DR (VTDR), and clinically significant macular edema (CSME). Projections of DR, VTDR, and CSME burden were based on population data from the IDF Atlas 2019. RESULTS: We included 59 population-based studies. Among individuals with diabetes, global prevalence was 22.27% (95% confidence interval [CI], 19.73%-25.03%) for DR, 6.17% (95% CI, 5.43%-6.98%) for VTDR, and 4.07% (95% CI, 3.42%-4.82%) for CSME. In 2020, the number of adults worldwide with DR, VTDR, and CSME was estimated to be 103.12 million, 28.54 million, and 18.83 million, respectively; by 2045, the numbers are projected to increase to 160.50 million, 44.82 million, and 28.61 million, respectively. Diabetic retinopathy prevalence was highest in Africa (35.90%) and North American and the Caribbean (33.30%) and was lowest in South and Central America (13.37%). In meta-regression models adjusting for habitation type, response rate, study year, and DR diagnostic method, Hispanics (odds ratio [OR], 2.92; 95% CI, 1.22-6.98) and Middle Easterners (OR, 2.44; 95% CI, 1.51-3.94) with diabetes were more likely to have DR compared with Asians. DISCUSSION: The global DR burden is expected to remain high through 2045, disproportionately affecting countries in the Middle East and North Africa and the Western Pacific. These updated estimates may guide DR screening, treatment, and public health care strategies.
引用
- Teo ZL, Tham YC, Yu M, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021. PMID: 33940045. doi:10.1016/j.ophtha.2021.04.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。